Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Systematic review of 1,002 studies (2,592,879 adults, 102 countries) with meta-analyses: pooled prevalence of ACE items was highest for emotional abuse (28.0%), parental divorce or separation (24.0%) and emotional neglect (22.1%), varying by demographics, region and method.
Meta-analysisn = 2,592,879
Madigan et al. Prevalence of adverse childhood experience items: a systematic review and meta-analysesGene burden meta-analysis of 748 879 people from three biobanks (20 026 with epilepsy) found rare coding variants in LGI1 significantly associated with epilepsy, and a suggestive signal for ADAM23, which interacts with LGI1, as a candidate gene.
Meta-analysisn = 748,879
Lal et al. Gene burden meta-analysis of 748 879 individuals identifies LGI1-ADAM23 protein complex association with epilepsyMeta-analysis of 20 observational studies (323,440 people, mostly adolescents): meeting one, two or three 24-hour movement guideline components was associated with lower odds of depression (ORs 0.73, 0.55, 0.41) and anxiety (0.74, 0.59, 0.43).
Meta-analysisn = 323,440
Zhao et al. Association between adherence to 24-hour movement guidelines and anxiety and depression: A systematic review and meta-analysis of observational studiesMeta-analysis of 31 studies (98,346 women): HPV self-sampling had pooled sensitivity 0.745 vs 0.886 for clinician-collected sampling for CIN2+, with similar specificity (0.850 vs 0.870); it was more sensitive than VIA and Pap cytology, with lower specificity than Pap.
Meta-analysisn = 98,346
Dixit et al. Comparative performance of HPV self-sampling and conventional screening methods: A systematic review and bivariate meta-analysisLong-term follow-up of a cluster-randomised trial in Nha Trang, Viet Nam: at 5·5 years a two-dose (1p+1) PCV10 schedule stayed non-inferior to three-dose schedules for vaccine-type carriage in infants (0·7% vs 1·9% and 0·9%) and toddlers.
RCTn = 49,644
Quilty et al. Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled trialIndividual participant data meta-analysis of surveys in 38,512 adults aged 18-65 from 15 countries: 13.7% reported headache yesterday (females 17.1%, males 9.7%); adjusted global 1-day prevalence 13.1%, with migraine 5.7%, TTH 3.9% and pMOH 2.4%.
Meta-analysisn = 38,512
Husøy et al. Over 600 million people aged 18-65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countriesMeta-analysis of 74 RCTs (over 29,000 patients) with skin IMIDs: JAK-STAT inhibitors vs placebo were associated with more influenza (RR 2.12), bronchitis (RR 2.03) and herpes zoster (RR 1.67), but not serious, fungal or opportunistic infections.
Meta-analysisn = 29,000
Krebs et al. Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patientsMeta-analysis of 51 studies (28,977 HPV-positive women): JAM3 (DOR 20.82), C13ORF18 (19.50) and PAX1 (17.13) methylation markers had the highest accuracy for CIN2+/CIN3+ triage; EPB41L3 had the lowest negative likelihood ratio (0.26).
Meta-analysisn = 28,977
Ellis et al. Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysisLiving systematic review of 41 RCTs (15,049 patients) in solid tumours: adding checkpoint inhibitors to radiotherapy did not significantly improve OS (HR 0.88, 95% CI 0.75–1.02; 28 trials), but did excluding glioblastoma (HR 0.83); PFS HR 0.80, EFS HR 0.73.
Meta-analysisn = 15,049
Tomassen et al. The survival impact of combining radiotherapy and immune checkpoint inhibitors in patients with solid tumors: A systematic review and living meta-analysis of randomized controlled trialsSystematic review and meta-analysis of 24 studies (13,087 people on HIV PrEP in routine care): pooled vaccination coverage was 73% for HBV, 61% for monkeypox, 59% for HAV and 43% for HPV, with high heterogeneity and often self-reported status.
Meta-analysisn = 13,087
Pascucci et al. Vaccination coverage among individuals receiving HIV pre-exposure prophylaxis (PrEP): A systematic review and meta-analysis